Stone House Investment Management »

Viking Therapeutics shares owned by Stone House Investment Management

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Stone House Investment Management from 13F filings

Historical chart of Stone House Investment Management investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Stone House Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Stone House Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.7k 250 18.61
2023-09-30 $2.8k 250 11.07
2023-06-30 $4.1k 250 16.21

More positions owned by Stone House Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Procter & Gamble Company (PG)
Ishares Tr Core Total Usd (IUSB)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Core Msci Total (IXUS)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Eafe Grwth Etf (EFG)
Ishares Tr Mbs Etf (MBB)
Ishares Tr TRS FLT RT BD (TFLO)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr U.s. Tech Etf (IYW)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ishares Tr S&p 100 Etf (OEF)

View all positions for Stone House Investment Management

Top funds holding Viking Therapeutics

Vanguard Group
Viking Global Investors
Alliancebernstein
Balyasny Asset Management
Deerfield Management Company
Goldman Sachs Group
Perpetual
Deutsche Bank Aktiengesellschaft
Charles Schwab Investment Management
Bank of America Corporation
Eventide Asset Management
Massachusetts Financial Services
683 Capital Management
5AM Venture Management
Citadel Advisors

View all funds holding Viking Therapeutics